NexxGen Incorporated is the parent company of two of our Advanced Genetic Testing Organizations.
NexxGen Genomics is our revolutionary Micro Array Testing Platform and Genomic Chip that delivers incredible sensitivity, automation, and high output. NexxGen Genomics harnesses our innovative Micro Array Genetic Testing Analyzer and Genomic Chip to deliver molecular assays and patient results for physicians and hospitals. What sets NexxGen Genomics apart is our automation, assay development, and low cost.
The world is forever changed due to COVID. One of the few bright spots that came out of this virus is a more in-depth patient understanding and support for molecular diagnostics. Laboratory Diagnostic companies are investing billions to unlock the power of molecular diagnostics to identify underlying or hereditary medical conditions.
Key Elements of our System
- Fully Automated
- Multiplexing
- High Output
- Sample to Result Automation
- High Sensitivity / Accuracy
NexxGen Laboratories provides hospitals, physicians, and researchers with highly accurate molecular testing results within 24 to 48 hours.
NexxGen Laboratories will utilize our advanced genomic technologies to provide accurate, timely, and cost-effective patient results. Our lab will be open to collaboration and training, to advance our genomics platform and assays to outside laboratories. Patients, hospitals, and physicians alike, will benefit from our sensitive and timely results.
NexxGen Laboratories will not only provide advanced genetic results but will also focus on toxicology, allergy, infectious diseases, and many other advanced testing methods.
Our use of artificial intelligence and easy-to-read reporting will support physicians while trying to identify some of our most troubling conditions.